What it is
Talk therapy helping you process and find meaning in psychedelic experiences, no substances involved.
Emerging evidence
Psychedelic Integration Therapy
The experience is just the beginning — integration is where lasting transformation happens.
CategoryComplementary
SafetyLow risk
Reviewed by Gyfts Editorial Team · Editorial Health Review
6 July 2026
At a glance
Psychedelic Integration Therapy at a glance
Why explore it
Helps you make sense of profound or difficult psychedelic experiences and turn insights into lasting change.
How it’s experienced
One-on-one sessions with a trained therapist using talk, journaling, or body-based approaches to ground your experience.
Evidence context
Integration is key in clinical trials, but standalone research is still early and practitioner quality varies widely.
See the evidence snapshotSafety
Low-risk since no substances are used, but choose a credentialed therapist and seek psychiatric care if needed.
See staying safeHistory & Origin
About Psychedelic Integration Therapy
Psychedelic Integration Therapy is a specialised psychotherapeutic practice focused on supporting individuals in making meaning from, and therapeutically processing, non-ordinary states of consciousness induced by psychedelic substances.
Psychedelic Integration emerged as a distinct therapeutic specialty in the 2010s as psychedelic research resumed internationally after decades of prohibition. The historical context includes: the first wave of clinical psychedelic research (1950s–1960s) which was largely curtailed by the scheduling of LSD, psilocybin, and MDMA; the gradual resumption of clinical trials from the 2000s onwards (led by institutions including Johns Hopkins, Imperial College London, and MAPS); and the growing recognition that psychedelic experiences — whether in clinical, ceremonial, or personal contexts — require skilled therapeutic support for optimal outcomes. Organisations such as the Multidisciplinary Association for Psychedelic Studies (MAPS), the Psychedelic Integration List, and the Psychedelic Support network established practitioner directories and training guidelines. Integration therapists typically hold conventional psychotherapy credentials supplemented by specialised training in psychedelic-specific protocols. The field bridges clinical psychedelic medicine, traditional plant medicine contexts, and harm reduction approaches.
Mechanism
How it works
Psychedelic Integration Therapy is generally framed as a guided process for attention, reflection, learning, and emotional integration. Depending on the method, a practitioner may use conversation, imagery, structured exercises, body awareness, or therapeutic techniques to help the person explore patterns and choices. It should not be presented as a standalone solution or a substitute for urgent care, but it may support self-understanding when practiced within an appropriate scope. Integration therapy addresses the gap between having a powerful psychedelic experience and translating its insights into lasting positive change in daily life.
- Shared FocusYou and your practitioner align on goals, boundaries, and what matters most.
- Guided ProcessSessions may use conversation, imagery, or creative tools at your own pace.
- Meaning MakingYou gently explore patterns, feelings, and insights that rise to the surface.
- Stabilizing SupportGrounding and pauses help keep the process feeling safe and manageable.
- Next StepsYour practitioner may suggest reflection, practice, or follow-up as needed.
Your first visit
What to expect from a session
A typical session outline to help you feel prepared
A warm, talk-based session where you and your therapist unpack the meaning of your psychedelic experience and explore how to carry its insights into everyday life.
Welcome and Check-In
Your therapist greets you and takes a few minutes to ask how you've been feeling since your last session or since your psychedelic experience, helping you settle in before any deeper work begins.
Setting the Container
Together you briefly revisit confidentiality and the no-judgment policy around substance use, so you feel fully safe speaking openly about what happened during your experience.
Recounting the Experience
You're invited to share your psychedelic experience in your own words and at your own pace, describing the visuals, emotions, body sensations, or encounters that stood out most to you.
Exploring Difficult Material
Your therapist gently guides you through any confusing, frightening, or emotionally charged moments from the experience, helping you sit with them rather than push them away.
Finding Meaning Together
You and your therapist look for recurring themes, symbols, or emotional threads that emerged during your experience and explore what they might mean in the context of your life.
Bridging Insight to Daily Life
The conversation shifts toward practical application, discussing specific changes, conversations, creative projects, or habits that feel aligned with what your experience revealed.
Grounding and Closing
Your therapist helps you arrive back in the present moment, often with a brief grounding exercise, before summarizing key takeaways and leaving you with something to reflect on before your next session.
The Evidence
Evidence context
What research says about psychedelic integration therapy, its role in clinical protocols, and what remains uncertain.
Overall pictureEmerging evidence
Integration is central to psychedelic therapy — but hard to study alone
Psychedelic integration therapy is an emerging specialty with a growing evidence base drawn from clinical trials where integration sessions are built into the protocol. Separating the therapeutic effect of integration from the substance effect remains a core methodological challenge.
What the research showsIntegration is embedded in major trials, making its independent effect difficult to isolate.
Landmark trials — including psilocybin for depression (Carhart-Harris et al., 2021, NEJM) and MDMA for PTSD (Mitchell et al., 2021, Nature Medicine) — include structured integration sessions as core protocol components. This makes the evidence base robust for the combined approach, but limited for integration therapy as a standalone intervention. Evidence is promising but not yet definitive.
Role in clinical protocolsIntegration sessions are not optional extras — they are considered essential to clinical outcomes.
Across major psychedelic research programmes at Johns Hopkins, Imperial College London, and MAPS, integration is treated as integral rather than supplementary. Gorman et al. (2021, Journal of Psychopharmacology) specifically examined integration in harm reduction contexts, finding it supports better outcomes and reduces adverse psychological effects following difficult experiences.
Where this fits in careIntegration therapy complements — it does not replace — conventional mental health support.
As a complementary modality, integration therapy works alongside existing psychological or psychiatric care. It is not a substitute for professional assessment in cases of severe mental health presentations. Its value lies in providing a specialised space to process experiences that conventional therapy frameworks may not be equipped to address.
Safety and legal considerationsIntegration therapy itself is legal; the substances it addresses may not be.
Integration therapy involves no administration of substances and is legal as a form of psychotherapy in all jurisdictions. Therapists must manage confidentiality carefully regarding disclosure of illegal substance use. This modality is not appropriate as a sole response to substance-induced psychosis, prolonged perceptual disturbances, or severe dissociative states — clear referral pathways to psychiatric care are essential.
Practitioner quality and trainingThe field is growing rapidly — practitioner quality and training vary considerably.
Qualified integration therapists typically hold recognised psychotherapy credentials supplemented by specialised training through programmes such as MAPS, Fluence, Naropa, or the California Institute of Integral Studies. The field lacks universal regulation, so verifying credentials and training background is important. Directories such as Psychedelic Support and the Psychedelic Integration List can assist in finding trained practitioners.
What remains uncertainEvidence is promising but the field is young and methodological challenges are significant.
Because integration is always delivered alongside a substance experience in clinical trials, its independent contribution cannot yet be precisely quantified. Qualitative research consistently highlights its value, but large-scale controlled studies of integration therapy alone are limited. Inflated outcome claims should be viewed with caution — this is an evolving area where the evidence base is still being established.
Safety first
Staying safe
General guidance to help you decide whether this approach is appropriate for you. This is informational only and not a substitute for medical, psychological, or professional advice.
When this may not be suitable
Some situations call for extra care or a different approach. Share any conditions, injuries, or sensitivities with your practitioner before your first session.
See specific guidance
- Integration therapy does not involve the provision or administration of any psychedelic substance. Therapists should hold conventional psychotherapy credentials and additional training in psychedelic-specific protocols. The legal status of psychedelic substances varies by jurisdiction — integration therapy itself is legal everywhere as it is a form of psychotherapy. Therapists must navigate confidentiality carefully, particularly regarding disclosure of illegal substance use. Integration therapy is not a substitute for psychiatric care in cases of substance-induced psychosis, prolonged perceptual disturbances (HPPD), or severe dissociative states — appropriate referral pathways should be established. The field is growing rapidly and practitioner quality varies — specialised training through recognised programmes (MAPS, Fluence, Naropa, California Institute of Integral Studies) provides quality assurance.
Check with a professional first
If you are pregnant, managing a health condition, recovering from injury or surgery, or taking medication, consult a qualified healthcare professional first.
Choosing a practitioner
Look for clear boundaries, transparent pricing, and practitioners who avoid fear-based claims or pressure to book frequent sessions.
Possible side effects or aftercare
Mild, short-lived effects such as tenderness, tiredness, or temporary soreness can occur. Rest, hydrate, and tell your practitioner how you respond.
For you?
Is this right for you?
A simple, human way to weigh it up. This is general guidance, not personal medical advice — a qualified practitioner can advise on your situation.
May be a good fit if…
- Individuals who have participated in clinical psychedelic trials and want continued processing support. Those who have had psychedelic experiences in legal ceremonial contexts (ayahuasca, ibogaine, peyote) and seek help integrating the experience. People who have had challenging or difficult psychedelic experiences (''bad trips'') they want to process therapeutically. Individuals experiencing ongoing psychological effects from past psychedelic use. Those preparing for upcoming psychedelic experiences in clinical or legal contexts.
May not be right if…
- People seeking a therapist to provide or facilitate access to psychedelic substances — integration therapists do not supply substances. Those in acute psychiatric crisis requiring immediate stabilisation. Individuals who are not comfortable discussing substance use with a therapist. People who have not had psychedelic experiences and are seeking general psychotherapy.
Gyfts is a discovery platform, not a medical provider. Nothing here diagnoses, treats or replaces professional care. In an emergency, contact your local emergency number.
Explore approaches
Related modalities
Other practices people often explore alongside psychedelic integration therapy.
In their words
People often describe it as
reflectivestructuredsupportiveemotionally spaciousclarifyingpacedcollaborativegrounding
FAQ
Common questions
Does integration therapy involve taking psychedelics?
No. Integration therapy is entirely a talking and processing therapy. The therapist does not provide, administer, or facilitate access to any psychedelic substance. It is legally practised worldwide as a form of psychotherapy.
Is integration therapy legal?
Yes. Integration therapy is a form of psychotherapy and is legal in all jurisdictions. The psychedelic substances themselves may be illegal, but providing therapeutic support for processing experiences with them is not.
What if I had a bad trip?
Challenging psychedelic experiences are a primary reason people seek integration therapy. A skilled integration therapist helps you process difficult, frightening, or confusing material therapeutically — reframing it as potentially meaningful psychological content rather than something to suppress.
How many sessions do I need?
This varies. Some people benefit from 3–4 sessions for a single experience. Complex experiences, ongoing psychedelic work, or deeper psychological processing may require 8–12 sessions or more. Your therapist will help determine an appropriate plan.
What qualifications should an integration therapist have?
Look for someone with conventional psychotherapy credentials (licensed therapist, psychologist, or counsellor) plus specialised training in psychedelic integration through recognised programmes such as MAPS, Fluence, CIIS, or Naropa.
Can integration therapy help with addiction?
Integration is a key component of psychedelic-assisted addiction treatment protocols (e.g., psilocybin for alcohol dependence). As standalone therapy, it can help individuals process experiences that may contribute to recovery insights.
Will my therapist report my drug use?
Integration therapists operate under standard psychotherapy confidentiality rules. Ethical guidelines in the field emphasise non-judgmental, confidential practice. However, confidentiality limits (mandatory reporting for harm to self or others) still apply as in any therapeutic context.
References
Evidence & Research
Educational sources that inform this overview. Inclusion is for context and does not imply endorsement.
- Trial of psilocybin versus escitalopram for depression
- MDMA-assisted therapy for severe PTSD: A phase 3 study
- Psychedelic harm reduction and integration: A transtheoretical model for clinical practice
- Patients'' accounts of increased connectedness and acceptance after psilocybin
- Effects of psilocybin-assisted therapy on major depressive disorder
Full citations are maintained by the Gyfts editorial team and reviewed periodically.
Keep exploring
Find Psychedelic Integration Therapy practitioners you can trust
Browse practitioners, explore honest overviews, and take what you learn to a conversation — at your own pace.